跳至主要内容
临床试验/JPRN-UMIN000036522
JPRN-UMIN000036522招募中未知

Investigator-initiated clinical trial for progressive supranuclear palsy using an anti-cholinergic drug - Clinical trial for PSP using anticholinergic drug

1) Department of Neurology, Gifu University Graduate School of Medicine, 2) National Hospital Organization, Higashi Nagoya Hospital0 个研究点目标入组 32 人开始时间: 2019年4月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) attending other clinical trials 2) alcohol dependence or drug abuser 3) psychiatric disorder 4) allergy for anti-cholinergic drugs 5) severe liver or renal dysfunction 6) effective for levodopa, and/or using following drugs: anti-psychiatric agents, anti-epileptic drugs, acethycholine esterase inhibitor, memantine, immunosuppressant, corticosteroids, anti-coagulant, lithium, or anti-cholinergic drug 7) not suitable for clinical trial judged by principal investigator or researchers.

研究者

发起方
1) Department of Neurology, Gifu University Graduate School of Medicine, 2) National Hospital Organization, Higashi Nagoya Hospital

相似试验